| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/02/2023 | 6.62% | Stifel | → $115 | Reiterates | Hold → Hold |
| 06/06/2023 | 6.62% | Truist Securities | $120 → $115 | Maintains | Hold |
| 04/12/2023 | 3.84% | Stifel | $110 → $112 | Maintains | Hold |
| 04/06/2023 | -10.07% | Goldman Sachs | $90 → $97 | Maintains | Sell |
| 04/04/2023 | 9.4% | Wells Fargo | $121 → $118 | Maintains | Equal-Weight |
| 04/04/2023 | 17.75% | Citigroup | $141 → $127 | Maintains | Buy |
| 01/03/2023 | 5.69% | Morgan Stanley | $108 → $114 | Downgrades | Overweight → Equal-Weight |
| 12/06/2022 | -12.85% | Goldman Sachs | $83 → $94 | Maintains | Sell |
| 11/17/2022 | 1.98% | Jefferies | → $110 | Downgrades | Buy → Hold |
| 06/08/2022 | -11.92% | Barclays | $90 → $95 | Maintains | Equal-Weight |
| 06/07/2022 | 11.26% | Cowen & Co. | $111 → $120 | Maintains | Outperform |
| 06/07/2022 | -11.92% | Barclays | $90 → $95 | Maintains | Equal-Weight |
| 04/01/2022 | -2.65% | Truist Securities | → $105 | Downgrades | Buy → Hold |
| 03/29/2022 | -8.21% | Morgan Stanley | $101 → $99 | Maintains | Overweight |
| 03/24/2022 | -11% | Wells Fargo | $90 → $96 | Maintains | Equal-Weight |
| 03/18/2022 | -6.36% | Morgan Stanley | $98 → $101 | Maintains | Overweight |
| 01/24/2022 | -16.56% | Barclays | $105 → $90 | Downgrades | Overweight → Equal-Weight |
| 01/03/2022 | -9.14% | Morgan Stanley | $101 → $98 | Maintains | Overweight |
| 12/07/2021 | -13.78% | Wells Fargo | $90 → $93 | Maintains | Equal-Weight |
| 10/27/2021 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 06/07/2021 | -6.36% | Morgan Stanley | $97 → $101 | Maintains | Overweight |
| 05/13/2021 | -11.92% | Wells Fargo | → $95 | Initiates Coverage On | → Equal-Weight |
| 05/12/2021 | -7.29% | Barclays | $107 → $100 | Maintains | Overweight |
| 04/07/2021 | -10.07% | Morgan Stanley | $107 → $97 | Maintains | Overweight |
| 04/05/2021 | -17.49% | Goldman Sachs | $96 → $89 | Downgrades | Buy → Neutral |
| 03/30/2021 | -11.92% | JP Morgan | $110 → $95 | Maintains | Overweight |
| 03/26/2021 | -2.65% | Citigroup | $115 → $105 | Maintains | Buy |
| 03/26/2021 | -16.56% | Stifel | → $90 | Downgrades | Buy → Hold |
| 12/04/2020 | -9.14% | Morgan Stanley | $94 → $98 | Maintains | Overweight |
| 09/03/2020 | -2.65% | Citigroup | $100 → $105 | Maintains | Buy |
| 05/19/2020 | -2.65% | Wells Fargo | $85 → $105 | Maintains | Overweight |
| 04/20/2020 | — | Goldman Sachs | Upgrades | Neutral → Buy | |
| 04/14/2020 | -12.85% | Morgan Stanley | $91 → $94 | Maintains | Overweight |
| 04/02/2020 | -11.92% | Stifel | → $95 | Upgrades | Hold → Buy |
| 03/31/2020 | -15.63% | Morgan Stanley | $85 → $91 | Maintains | Overweight |
| 03/31/2020 | — | William Blair | Initiates Coverage On | → Outperform | |
| 03/30/2020 | -11.92% | SunTrust Robinson Humphrey | $110 → $95 | Maintains | Buy |
| 03/27/2020 | -7.29% | Citigroup | $105 → $100 | Maintains | Buy |
| 03/27/2020 | -21.19% | Wells Fargo | $105 → $85 | Maintains | Overweight |
| 03/27/2020 | -2.65% | Benchmark | $115 → $105 | Maintains | Buy |
| 03/24/2020 | -21.19% | Morgan Stanley | $108 → $85 | Maintains | Overweight |
| 01/31/2020 | — | Benchmark | Initiates Coverage On | → Buy | |
| 01/09/2020 | -7.29% | Wells Fargo | $92 → $100 | Maintains | Overweight |
| 09/24/2019 | -5.43% | JP Morgan | → $102 | Initiates Coverage On | → Overweight |
| 09/20/2019 | -2.65% | Barclays | → $105 | Initiates Coverage On | → Overweight |
| 09/09/2019 | — | Cowen & Co. | Upgrades | Market Perform → Outperform | |
| 06/03/2019 | -11% | Morgan Stanley | → $96 | Initiates Coverage On | → Overweight |
| 05/16/2019 | — | Wells Fargo | Upgrades | Market Perform → Outperform | |
| 05/09/2019 | -28.61% | Goldman Sachs | → $77 | Initiates Coverage On | → Neutral |
| 03/29/2019 | -28.61% | Wells Fargo | $70 → $77 | Maintains | Market Perform |
| 03/29/2019 | — | Vertical Research | Upgrades | Hold → Buy | |
| 12/07/2018 | -30.47% | Wells Fargo | $84 → $75 | Maintains | Market Perform |
What is the target price for Science Applications Intl (SAIC)?
The latest price target for Science Applications Intl (NYSE: SAIC) was reported by Stifel on October 2, 2023. The analyst firm set a price target for $115.00 expecting SAIC to rise to within 12 months (a possible 6.62% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Science Applications Intl (SAIC)?
The latest analyst rating for Science Applications Intl (NYSE: SAIC) was provided by Stifel, and Science Applications Intl reiterated their hold rating.
When is the next analyst rating going to be posted or updated for Science Applications Intl (SAIC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Science Applications Intl, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Science Applications Intl was filed on October 2, 2023 so you should expect the next rating to be made available sometime around October 2, 2024.
Is the Analyst Rating Science Applications Intl (SAIC) correct?
While ratings are subjective and will change, the latest Science Applications Intl (SAIC) rating was a reiterated with a price target of $0.00 to $115.00. The current price Science Applications Intl (SAIC) is trading at is $107.86, which is within the analyst's predicted range.